IBTK_XENLA
ID IBTK_XENLA Reviewed; 1339 AA.
AC Q6NRS1;
DT 20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT 05-JUL-2004, sequence version 1.
DT 03-AUG-2022, entry version 80.
DE RecName: Full=Inhibitor of Bruton tyrosine kinase;
DE Short=IBtk;
GN Name=ibtk;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Kidney;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Acts as an inhibitor of BTK tyrosine kinase activity, thereby
CC playing a role in B-cell development. {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250};
CC Peripheral membrane protein {ECO:0000250}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC070653; AAH70653.1; -; mRNA.
DR RefSeq; NP_001084927.1; NM_001091458.1.
DR AlphaFoldDB; Q6NRS1; -.
DR SMR; Q6NRS1; -.
DR MaxQB; Q6NRS1; -.
DR DNASU; 431983; -.
DR GeneID; 431983; -.
DR KEGG; xla:431983; -.
DR CTD; 431983; -.
DR Xenbase; XB-GENE-5756000; ibtk.L.
DR OrthoDB; 94875at2759; -.
DR Proteomes; UP000186698; Chromosome 5L.
DR Bgee; 431983; Expressed in zone of skin and 19 other tissues.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR Gene3D; 1.25.40.20; -; 1.
DR Gene3D; 2.130.10.30; -; 1.
DR Gene3D; 3.30.710.10; -; 2.
DR InterPro; IPR002110; Ankyrin_rpt.
DR InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR InterPro; IPR000210; BTB/POZ_dom.
DR InterPro; IPR009091; RCC1/BLIP-II.
DR InterPro; IPR000408; Reg_chr_condens.
DR InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR Pfam; PF12796; Ank_2; 1.
DR Pfam; PF00651; BTB; 2.
DR Pfam; PF00415; RCC1; 3.
DR PRINTS; PR00633; RCCNDNSATION.
DR SMART; SM00248; ANK; 2.
DR SMART; SM00225; BTB; 2.
DR SUPFAM; SSF48403; SSF48403; 1.
DR SUPFAM; SSF50985; SSF50985; 1.
DR SUPFAM; SSF54695; SSF54695; 2.
DR PROSITE; PS50297; ANK_REP_REGION; 1.
DR PROSITE; PS50088; ANK_REPEAT; 1.
DR PROSITE; PS50097; BTB; 2.
DR PROSITE; PS50012; RCC1_3; 3.
PE 2: Evidence at transcript level;
KW ANK repeat; Cytoplasm; Membrane; Reference proteome; Repeat.
FT CHAIN 1..1339
FT /note="Inhibitor of Bruton tyrosine kinase"
FT /id="PRO_0000280278"
FT REPEAT 51..81
FT /note="ANK 1"
FT REPEAT 86..115
FT /note="ANK 2"
FT REPEAT 119..154
FT /note="ANK 3"
FT REPEAT 142..195
FT /note="RCC1 1"
FT REPEAT 196..247
FT /note="RCC1 2"
FT REPEAT 249..302
FT /note="RCC1 3"
FT DOMAIN 555..636
FT /note="BTB 1"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00037"
FT DOMAIN 758..826
FT /note="BTB 2"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00037"
FT REGION 685..704
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 970..993
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1058..1089
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 1208..1237
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 685..702
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1062..1089
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 1215..1229
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1339 AA; 149341 MW; 483977396F30E5B4 CRC64;
MERVWPECTT RCRSLQHALD VISVVTRASE QHIKVFLSSY CCNAVTLKDD FGRNATHIAA
SCGKKNVLDW LITGKGVDLA VKDKESGWTA LHRSIFYGHI DCALSLLKHG SNLYIQDKDG
YTPLDLVMKD RPPHIVFKTS DPTELYTWGD NVNFTLGHGT QQSKHHPELV EMFPRSGVYI
KQMVLCKFHS VFLSQKGQVY TCGHGQGGRL GHGDELTCLV PRLVEGLRGH PCTQVAGAKD
HTVVLTEDGY VYTFGLNTFH QLGIQPPPPN SNVPRQIQAK TMKGKTVLGV AAGRFHTVLW
TKDAVYTVGL NGGQLGYLQD PNGEKFVSCP RQVSALHHKD INITLVSASD GATVCVSERG
DIYLLSEYQC KKLASKQLNL KKVLVSGGIL EHKAAPEHLK ENGGQPASVF ALDQAGRVFC
WKSPGSSLKQ CWWVYGRQLF MSDVALNKNE IMFVTQDGEG FTGKWMLEKK KKENTISNIM
CHSDSQNVYE KISMQKLPFV HRAVSVATDP SGCNFAVLQS DPKTSLFEVP SVSSSVFAED
FEKLLNEANE TDSIHDVTFQ VGTKIFPAHK YILALRCDFF SKLFSSGEIN SLDFPEVHQK
GEDAAGCDLF VIEKIPPELF SHVLQFIYSD TCDMLLQGHK PKLWHKEENE NTIICNFQKM
GFREDIEGKS AYEVYKNSRI CAENEKQKGK TKQSKKTRSI GDETSPVKML QNTAKKFGLS
NLSSRLDGVR YENGRINVFH KKSENKLRFN QKKCSSHYDV MMKSEDGKEF HCHKCVLCAR
LEYFNSMLSS SWIEASCCSQ LEMPIHSDVL QVILDYIYTD EVLTVKESAN VEFVCNVLVI
ADQLLIVRLK EICEVTIAER ITLKNAAELL EFAALYNADQ LKLSCLQFVG LNMGALLEAR
SLDVLSDDVL KDLSEAYRKM IPSMNKRIIT PYLDGPDISI LQSEDIESLI SVQDDIYSYQ
ITQEATLKKS KAKPKKKQRK RLDSSGGYNL SDIIQSPTST GFVKPEKTNS VESLQDLLTS
DSEGSFVGAS SPRDLQSPDL FPVFTHETKE TICVERNRSS PPVANGAAST KMPIPTTSSP
KAIPMSRITP STSPNWVAMP CSPASPVTMD LRAIMELEEN IQKCGAMPKL NAGGTKPGTH
VMKLSQKQRK MMAMSSKESN NENKPAKVTV APTTIKSPAK TWAAAFHLGE NKSFRDLLLE
EKQSVTSFPS LSSDVKKSKH TEELDPSELA RRPSGTLNQE AKLKCDVPNQ DNSNPWHLTL
SKNNASSAPV TFTAIVEEEE KQEAALIRSR EKPLALIQIE ERAIQDLLLH YQAIDNPEEY
ITIERAAQIP MATPMWNKH